Oncolytics Biotech
(TSX) ONC
This security has been delisted. This page is retained for historical reference.
ONC News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowONC Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
52%
Return on Capital
-13%
Return on Assets
-4%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
-CA$424.00K
Operating Income
-CA$34.98M
EBITDA
-CA$34.88M
Operating Cash Flow
-CA$26.97M
Capital Expenditure
-CA$239.00K
Free Cash Flow
-CA$27.21M
Cash & ST Invst.
CA$15.94M
Total Debt
CA$1.06M
Oncolytics Biotech Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
CA$0.00
N/A
Gross Profit
-CA$94.00K
+4.1%
Gross Margin
0.00%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
28
N/A
Net Income
-CA$6.17M
+15.0%
EBITDA
-CA$5.61M
+28.9%
Quarterly Fundamentals
Total Cash
CA$14.63M
-41.1%
Total Debt
CA$888.00K
-20.4%
Accounts Receivable
CA$72.00K
-95.4%
Inventory
CA$0.00
N/A
Long Term Debt
CA$597.00K
-33.0%
Short Term Debt
CA$582.00K
+158.7%
Return on Assets
-4.35%
N/A
Return on Invested Capital
-12.96%
N/A
Free Cash Flow
-CA$5.47M
-78348.5%
Operating Cash Flow
-CA$5.47M
-80131.7%